United States Renal Disease Treatment Market was valued at USD 30 Billion in 2022 and is projected to reach USD 42 Billion by 2030, growing at a CAGR of 4.7% from 2024 to 2030.
The US Renal Disease Treatment Market is experiencing significant growth as the prevalence of kidney-related disorders continues to rise across the nation. This market encompasses various treatment modalities and products aimed at managing chronic kidney diseases (CKD), end-stage renal disease (ESRD), and other renal complications. The increasing demand for dialysis, kidney transplant services, and pharmaceutical treatments has driven advancements and innovation in this sector.
In terms of market type, dialysis treatment remains the dominant segment in the US Renal Disease Treatment Market. Hemodialysis and peritoneal dialysis are the most common treatment methods, with hemodialysis accounting for the largest share. The requirement for dialysis is primarily fueled by the increasing number of individuals diagnosed with ESRD. According to recent statistics, millions of Americans suffer from some form of kidney disease, and dialysis serves as a critical treatment option for these patients.
Additionally, kidney transplant procedures are also a significant contributor to the market, although the demand often exceeds the availability of donor organs. Pharmaceutical treatments aimed at managing conditions such as hypertension and diabetes, which contribute to kidney damage, are also gaining traction in the market. These treatments help slow the progression of kidney disease and alleviate symptoms.
Industries involved in the US Renal Disease Treatment Market include healthcare providers, medical device manufacturers, and pharmaceutical companies. Healthcare providers, including hospitals and dialysis centers, play a vital role in delivering patient care and implementing treatment regimens. Medical device companies develop and supply dialysis machines, pumps, and other essential equipment used in renal care. Pharmaceutical companies contribute by developing drugs that target the underlying causes of kidney disease, offering solutions to improve patient outcomes.
In the future, as the aging population grows and the prevalence of risk factors like obesity and diabetes increases, the demand for renal disease treatments is expected to surge. Industry players are likely to see continued growth in both the demand for dialysis products and innovative pharmaceutical treatments. This expansion will continue to shape the landscape of the US Renal Disease Treatment Market and influence the development of new solutions aimed at enhancing kidney care.
Get an In-Depth Research Analysis of the US Renal Disease Treatment Market Size And Forecast [2025-2032]
Abbott
Amgen
Baxter
Bristol-Myers Squibb Company
Keryx Biopharmaceuticals
NephroGenex
Novartis AG
Pfizer
Sanofi
Shire Pharmaceuticals Limited
CTI BioPharma Corp
Merck
Prolong Pharmaceuticals
VESSL Therapeutics
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Renal Disease Treatment Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Renal Disease Treatment Market
Dialysis
Kidney Transplantation
Medication
Others
Chronic Kidney Disease (CKD)
Acute Kidney Injury (AKI)
End-Stage Renal Disease (ESRD)
Oral
Injectable
Others
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Angiotensin-Converting Enzyme (ACE) Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Diuretics
Immunosuppressants
Others
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Renal Disease Treatment Market Research Analysis
1. Introduction of the US Renal Disease Treatment Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Renal Disease Treatment Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Renal Disease Treatment Market, By Type
6. US Renal Disease Treatment Market, By Application
7. US Renal Disease Treatment Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Renal Disease Treatment Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/